GlycanAge

The Ultimate Measure of Inflammaging

Newcastle upon Tyne, United Kingdom · Founded 2020 · $7.4M raised

Employees
11–50
Founded
2020
Business Model
B2C
Total Funding
$7.4M
Last Round
$7.4M Venture RoundDec 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

GlycanAge is a UK-based biotech company that uses glycan biomarkers to measure biological aging and chronic inflammation. Its test analyzes IgG glycans—the immune system's molecular record—to provide the most sensitive signal of inflammaging, enabling early detection of health risks years before clinical disease appears. Founded in 2020 by Professor Gordan Lauc (CSO) and Nikolina Lauc (CEO), the science is backed by over 30 years of research and 350+ peer-reviewed publications. GlycanAge serves individuals, healthcare providers, and researchers, offering at-home testing kits and clinical integrations. The company is headquartered in Newcastle upon Tyne, UK.

Summary

GlycanAge is a Biotech company based in Newcastle upon Tyne, United Kingdom, founded in 2020. It has raised $7.4M in total across 1 round, most recently a $7.4M Venture Round in Dec 2025. Investors include Fifth Quarter Ventures and Guinness Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundGrowth FundingDec 2025
$7.4M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GlycanAge on Indexed.vc
<a href="https://indexed.vc/companies/glycanage"><img src="https://indexed.vc/api/badge/company/glycanage" alt="GlycanAge on Indexed.vc" width="260" height="76" /></a>